Modern Chinese Medicine Group Co. Ltd. (HK:1643) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Modern Chinese Medicine Group Co. Ltd. has reported a significant downturn in its financial performance for the first half of 2024, with revenues plummeting by 57.5% to RMB 76.6 million, and gross profits falling by 63.3% to RMB 21.7 million. The company also swung to a loss of RMB 6.9 million, compared to a profit of RMB 27.6 million in the same period last year. This stark contrast underscores challenges faced by the company, with earnings per share dropping from RMB 4.6 cents profit to RMB 1.14 cents loss.
For further insights into HK:1643 stock, check out TipRanks’ Stock Analysis page.

